Seeking Alpha

Healthcare upgrades, downgrades, and initiations for Friday

  • Ironwood Pharmaceuticals (IRWD +4.9%) upgraded to Outperform from Market Perform at BMO. Price target is $16.
  • Bristol-Myers Squibb (BMY +0.7%upgraded to Overweight from Equalweight at Barclays. Price target hiked to $65 from $52.
  • Sequenom (SQNM -3.4%) cut to Neutral from Overweight at Piper. Price target is $2.50.
  • BioMarin (BMRN -2.2%cut to Equalweight from Overweight at Barclays. Price target is $73.
  • Johnson & Johnson (JNJ -0.5%cut to Equalweight from Overweight at Barclays. Price target is $99.
  • Pfizer (PFE -0.6%cut to Market Perform at Cowen. Price target is $34.
  • Eli Lilly (LLY -0.4%) downgraded to Underweight from Equalweight at Barclays. Price target cut to $51 from $58.
  • H.C. Wainwright starts Celsion (CLSN +7.7%) at Buy. Price target is $8.
  • Orexigen (OREX +1.1%initiated at Buy with a $9 target at Wallachbeth.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|